| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | CA2083271C Fibrin binding domain polypeptides and uses and methods of producing same |
| 04/04/2002 | WO2002026822A2 Pumpcn compositions and uses thereof |
| 04/04/2002 | WO2002026748A2 Metal complexes for use in medical and therapeutic applications |
| 04/04/2002 | WO2002006248A3 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 04/04/2002 | WO2001098327A3 Glycopeptide carboxy-saccharide derivatives |
| 04/04/2002 | WO2001098326A3 Glycopeptide disulfide and thioester derivatives |
| 04/04/2002 | WO2001097678A3 Imaging and targeting tumors using sickle cells |
| 04/04/2002 | WO2001072846A3 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
| 04/04/2002 | US20020039599 Calibration; administering antiseptic compound |
| 04/04/2002 | US20020039581 Antibodies against CTLA4 and uses therefor |
| 04/04/2002 | US20020039557 Anticarcinogenic agents; immunosuppressant |
| 04/04/2002 | DE10044559A1 Beschichtetes Implantat Coated implant |
| 04/04/2002 | CA2423991A1 Pumpcn compositions and uses thereof |
| 04/04/2002 | CA2420645A1 Metal complexes for use in medical and therapeutic applications |
| 04/04/2002 | CA2420577A1 Peptide-based compounds |
| 04/03/2002 | EP1193260A1 Phenoxazine analogs for the treatment of amyloidosis |
| 04/03/2002 | EP1192166A1 Group(vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them |
| 04/03/2002 | EP1192144A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids |
| 04/03/2002 | EP1192143A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 04/03/2002 | EP1192131A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 04/03/2002 | EP1191948A2 High dose radionuclide complexes for bone marrow suppression |
| 04/03/2002 | EP1191947A1 Methods for treating avm' using radioactive compositions |
| 04/03/2002 | EP0883627B1 Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 04/03/2002 | EP0738158B1 Biological targeting agents |
| 04/03/2002 | EP0621786B1 Induced tolerance to xenografts |
| 04/03/2002 | CN1343130A Radioactive cisplatin in treatment of cancer |
| 03/29/2002 | CA2357450A1 Phenoxazine analogs useful as amyloid aggregation inhibitors and treatment of alzheimer's disease and disorders related to amyloidosis |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | WO2002024695A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 03/28/2002 | WO2002024652A1 Compounds and methods for diagnosing and treating amyloid-related conditions |
| 03/28/2002 | WO2002024235A2 Prochelators of radiometal labeled molecules |
| 03/28/2002 | WO2001080880A3 Apoptotic agents |
| 03/28/2002 | WO2001044177A3 Somatostatin analogs, radiolabelled derivatives thereof and their use |
| 03/28/2002 | US20020037540 Nucleotide sequences coding preferential tumor markers; for use tools in tumor detection and treatment |
| 03/28/2002 | US20020037289 Combined methods and compositions for tumor vasculature targeting and tumor treatment |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 03/28/2002 | DE10040858A1 Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with polar radicals, process for their preparation and their use |
| 03/28/2002 | CA2423284A1 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 03/28/2002 | CA2422911A1 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | CA2420862A1 Protein phosphatases |
| 03/27/2002 | CN1342096A Synergistic tumorcidal response induced by histamine |
| 03/27/2002 | CN1341454A Preparation process of source core of iodine-12.5 granule sealed seed source |
| 03/21/2002 | WO2002022000A2 Targeted alpha particle therapy using actinium-225 conjugates |
| 03/21/2002 | WO2001062905A3 Integrin antagonists |
| 03/21/2002 | WO2001037779A3 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 03/21/2002 | WO2001034196A3 Mixture containing rare earths and use thereof |
| 03/21/2002 | US20020035122 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 03/21/2002 | US20020034730 For identifying compounds that bind to ion channel and may have antiarrhythmic activity |
| 03/21/2002 | US20020034511 Radioactive labeling of biotin |
| 03/21/2002 | US20020034474 Drug targeting system, method of its preparation and its use |
| 03/20/2002 | EP1187919A2 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 03/20/2002 | EP1187848A1 Annexin derivatives with endogenous chelation sites |
| 03/20/2002 | EP1187637A2 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 03/20/2002 | EP1187630A1 Rapid immunoassay to detect antibodies in saliva to disease-related microorganisms antigens |
| 03/20/2002 | EP0418316B1 Platelet-specific chimeric immunoglobulin |
| 03/19/2002 | US6359120 Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| 03/19/2002 | US6359119 Reacting a metal in permetallate form in a mixture with carbon monoxide and a reducing agent comprising stannous salt to form carbonyl complex |
| 03/19/2002 | US6359111 Useful in treating cancer, and in a method of imaging opioid receptors either inside or outside of the central nervous system |
| 03/19/2002 | US6358492 Dopamine transporter imaging ligand |
| 03/19/2002 | US6358491 Somatostatin analogs |
| 03/19/2002 | US6358490 Biotin conjugated to therapeutic or diagnostic radionuclides or other active agents such as chemotherapeutic drugs, antitumor agents such as cytokines enhances active agent localization |
| 03/19/2002 | US6358489 Fluorination of proteins and peptides for F-18 positron emission tomography |
| 03/19/2002 | US6358194 Medical use of xenon-133 in radiation therapy of cancer |
| 03/19/2002 | CA2136330C Technetium-99m labeled peptides for thrombus imaging |
| 03/19/2002 | CA1341349C Functionalized polyamine chelants and rhodium complexes thereof for conjugation to antibodies |
| 03/14/2002 | WO2002020610A2 Conformationally constrained labeled peptides for imaging and therapy |
| 03/14/2002 | WO2002020434A1 Synthesis of 17f labeled fluoroalkanes |
| 03/14/2002 | WO2002020062A2 Coated implant |
| 03/14/2002 | WO2002020061A1 Preparations for diagnosing extrapancreatic secretory function |
| 03/14/2002 | WO2001076644A3 Lipid-based systems for targeting diagnostic agents |
| 03/14/2002 | WO2001076555A3 Lipid-based drug delivery systems for topical application |
| 03/14/2002 | US20020031492 Providing a brain tumor sample, quantifying the expression of an interleukin-13 (IL-13) receptor in the sample; and correlating the quantity of expression of the IL-13 receptor with the tumor type or grade; prognosis |
| 03/14/2002 | DE10040771A1 Neue, 224Ra enthaltende, radiotherapeutisch wirksame Formulierungen und Verfahren zu ihrer Herstellung New, high 224Ra, radio therapeutically effective formulations and methods for their preparation |
| 03/14/2002 | CA2730627A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2419726A1 Preparations for diagnosing extrapancreatic secretory function |
| 03/13/2002 | EP1186306A1 Labeled nucleosides and method for their preparation |
| 03/13/2002 | EP1185526A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 03/13/2002 | EP1185307A2 Methods of imaging and targeting tumor vasculature |
| 03/13/2002 | EP0930844A4 Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent |
| 03/12/2002 | US6355444 Detecting cancer marker in sample; obtain hybridoma sample, incubate with antibody, detect bound antibody |
| 03/12/2002 | CA2016235C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 03/07/2002 | WO2002018576A2 Compositions and methods relating to lung specific genes |
| 03/07/2002 | WO2002018440A1 Anti-angiogenic peptides |
| 03/07/2002 | WO2002017970A2 Metal radionuclide labelled cd-30 antibodies and uses thereof |
| 03/07/2002 | WO2002017969A2 Reagents and methods for the diagnosis of cmv dissemination |
| 03/07/2002 | WO2001042220A3 Podate ligands and methods of use thereof |
| 03/07/2002 | WO2001021219A3 Imaging of drug accumulation as a guide to antitumor therapy |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028770 Bactericides |
| 03/07/2002 | US20020028178 Treating CD40+ malignancies comprising administering a therapeutically effective amount of an antibody or antibody fragment which binds to CD40L thereby inhibiting CD40/CD40L interaction or CD40 signaling. |
| 03/07/2002 | US20020028177 Synthesis of 17F labeled fluoroalkanes |
| 03/07/2002 | CA2420765A1 Anti-angiogenic peptides |
| 03/06/2002 | EP1183695A1 Sterile radioactive seeds |
| 03/06/2002 | CN1338923A Method for controlling liposome size |
| 03/06/2002 | CN1080127C Ternary radiopharmaceutical complexes |
| 03/05/2002 | US6353105 Inhibitors of 5-hydroxy-tryptamine reuptake of a monoamine transporter; analogs of cocaine; |